Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05PNO
|
|||
| Former ID |
DNC007185
|
|||
| Drug Name |
1-(2-iodoethyl)-1H-indole-2,3-dione
|
|||
| Synonyms |
1-(2-iodoethyl)indole-2,3-dione; AC1N4VNK; Isatin-based compound, 6; CHEMBL376518; BDBM22786; ZINC5738958; AKOS024343322; MCULE-9804545910; 1-(2-IODO-ETHYL)-1H-INDOLE-2,3-DIONE
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H8INO2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C(=O)N2CCI
|
|||
| InChI |
1S/C10H8INO2/c11-5-6-12-8-4-2-1-3-7(8)9(13)10(12)14/h1-4H,5-6H2
|
|||
| InChIKey |
OBYVXAUONRVYHA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Liver carboxylesterase (CES1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Drug metabolism - other enzymes | |||
| Metabolic pathways | ||||
| Pathway Interaction Database | E2F transcription factor network | |||
| WikiPathways | NRF2 pathway | |||
| Nuclear Receptors Meta-Pathway | ||||
| Heroin metabolism | ||||
| Irinotecan Pathway | ||||
| Fluoropyrimidine Activity | ||||
| Phase I biotransformations, non P450 | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective inhibition of carboxylesterases by isatins, indole-2,3-diones. J Med Chem. 2007 Apr 19;50(8):1876-85. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.